相关实验视频
Updated: Jul 19, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
长期发展的肺部原发性恶性黑色素瘤:一个病例报告
Yusei Fukushima1, Masanori Azuma1, Yoshimi Miyagi2
1Department of Respiratory Medicine Osaka Saiseikai Nakatsu Hospital Osaka City Osaka Japan.
Respirology case reports
|January 16, 2026
概括
这项研究详细介绍了一例罕见的原发性肺恶性黑色素瘤 (PMML) 病例,该病例发生在患有慢性肺炎的患者身上. 免疫疗法显示出反应,但疾病的进展导致了致命的结果,这表明免疫疗法.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 一名66岁的男性出现了20年的复发性血栓塞病史.
- 最初的CT扫描显示了轻度支气管切开和线性不透明,在10年内进展为质量.
- 肺结节形成,活检证实恶性黑色素瘤没有其他主要部位.
研究的目的:
- 报告一种罕见的原发性肺恶性黑色素瘤 (PMML) 病例.
- 调查慢性气道炎症与瘤发展之间的潜在关联.
- 评估免疫疗法在治疗PMML中的作用.
主要方法:
- 一个患有PMML的患者的病例报告.
- 诊断工作包括CT,皮肤学检查和PET-CT.
- 用尼沃卢马布治疗和随后的疾病监测.
- 尸检以评估瘤的反应和传播.
主要成果:
- 在肺部诊断出恶性黑色素瘤时,没有其他原发性病变的证据.
- 尼沃卢马布治疗导致疾病稳定8个月,表明治疗反应.
- 尸体解剖显示瘤缩和CD8+T细胞透,证实了对免疫治疗的反应.
- 免疫疗法开始后14个月发生了快速的疾病进展和死亡.
结论:
- 慢性呼吸道炎症可能与原发性肺恶性黑色素瘤的发展有关.
- 免疫疗法,如尼沃卢马布,可以诱导PMML的治疗反应.
- 尽管初始反应,PMML可以表现出积极的进展,突出需要进一步研究治疗策略.
相关概念视频
Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

